Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Significance of Preoperative Inflammatory Parameters in Gastric Cancer Patients

  • Lee, Deuk Young (Department of Surgery, Inje University Seoul Paik Hospital) ;
  • Hong, Seong Woo (Department of Surgery, Inje University Seoul Paik Hospital) ;
  • Chang, Yeo Goo (Department of Surgery, Inje University Seoul Paik Hospital) ;
  • Lee, Woo Yong (Department of Surgery, Inje University Seoul Paik Hospital) ;
  • Lee, Byungmo (Department of Surgery, Inje University Seoul Paik Hospital)
  • Received : 2013.05.10
  • Accepted : 2013.05.30
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Chronic inflammation induces cancer and cancer induces local tissue damage with systemic inflammation. Therefore, the aim of this study is to investigate the potential relationship between the severity of inflammation and prognosis in cancer patients. Materials and Methods: This study enrolled 220 patients from January 2002 to December 2006 who underwent gastric surgery. We evaluated the relationship between preoperative inflammatory parameters (erythrocyte sedimentation rate, neutrophil-to-lymphocyte ratio) and other clinicopathological factors. Survival outcomes were compared according to the extent of inflammation. Results: Significant elevation of erythrocyte sedimentation rate was related with old age, increased neutrophil-to-lymphocyte ratio, decreased hemoglobin, increased carcinoembryonic antigen, increased tumor size and advanced TNM stage. Neutrophil-to-lymphocyte ratio was significantly correlated with old age, increased erythrocyte sedimentation rate and advanced TNM stage. In the univariate analysis, elevated erythrocyte sedimentation rate and increased neutrophil-to-lymphocyte ratio had significantly poorer survival than those without elevation (all P<0.05). However, the multivariate analysis failed to prove erythrocyte sedimentation rate and neutrophil-tolymphocyte ratio as independent prognostic factors. Conclusions: The elevation of erythrocyte sedimentation rate and neutrophil-to-lymphocyte ratio were correlated with poor prognosis in the univariate analysis and there was a strong correlation between inflammatory parameters (erythrocyte sedimentation rate and neutrophil- to-lymphocyte ratio) and tumor progression. Thus, erythrocyte sedimentation rate and neutrophil-to-lymphocyte ratio are considered useful as follow-up factors.

Keywords

References

  1. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24. https://doi.org/10.4143/crt.2012.44.1.11
  2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867. https://doi.org/10.1038/nature01322
  3. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000;248:171- https://doi.org/10.1046/j.1365-2796.2000.00742.x
  4. Yamashita H, Katai H. Systemic inflammatory response in gastric cancer. World J Surg 2010;34:2399-2400. https://doi.org/10.1007/s00268-010-0703-1
  5. Lukaszewicz-Zając M, Mroczko B, Gryko M, Kędra B, Szmitkowski M. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med 2011;11:89-96. https://doi.org/10.1007/s10238-010-0114-5
  6. Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 2010;16:5805-5813. https://doi.org/10.1158/1078-0432.CCR-10-2245
  7. Jeong JH, Lim SM, Yun JY, Rhee GW, Lim JY, Cho JY, et al. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Oncology 2012;83:292-299. https://doi.org/10.1159/000342376
  8. Hwang JE, Kim HN, Kim DE, Choi HJ, Jung SH, Shim HJ, et al. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer 2011;11:489. https://doi.org/10.1186/1471-2407-11-489
  9. Nozoe T, Iguchi T, Adachi E, Matsukuma A, Ezaki T. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer. Surg Today 2011;41:510-513. https://doi.org/10.1007/s00595-009-4297-x
  10. Chang CC, Sun CF, Pai HJ, Wang WK, Hsieh CC, Kuo LM, et al. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance. Chang Gung Med J 2010;33:301-312.
  11. Mönig H, Marquardt D, Arendt T, Kloehn S. Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy. Fam Pract 2002;19:436-438. https://doi.org/10.1093/fampra/19.5.436
  12. Wang CS, Sun CF. C-reactive protein and malignancy: clinicopathological association and therapeutic implication. Chang Gung Med J 2009;32:471-482.
  13. Alao OO. Clinical utility of the erythrocyte sedimentation rate. J Clin Med Res 2010;2:119-124.
  14. Feldman M, Aziz B, Kang GN, Opondo MA, Belz RK, Sellers C. C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults. Transl Res 2013;161:37-43. https://doi.org/10.1016/j.trsl.2012.07.006
  15. Todorovic M, Balint B, Jevtic M, Suvajdzic N, Ceric A, Stamatovic D, et al. Primary gastric mucosa associated lymphoid tissue lymphoma: clinical data predicted treatment outcome. World J Gastroenterol 2008;14:2388-2393. https://doi.org/10.3748/wjg.14.2388
  16. Wu Y, Fu X, Zhu X, He X, Zou C, Han Y, et al. Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis. J Cancer Res Clin Oncol 2011;137:887-896. https://doi.org/10.1007/s00432-010-0951-3
  17. van den Tol MP, ten Raa S, van Grevenstein WM, van Rossen ME, Jeekel J, van Eijck CH. The post-surgical inflammatory response provokes enhanced tumour recurrence: a crucial role for neutrophils. Dig Surg 2007;24:388-394. https://doi.org/10.1159/000107781
  18. Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 2009;69:5383-5391. https://doi.org/10.1158/0008-5472.CAN-08-3845

Cited by

  1. Neutrophil-to-Lymphocyte Ratio in Prognosis of Gastric Cancer vol.13, pp.3, 2013, https://doi.org/10.5230/jgc.2013.13.3.196
  2. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population vol.35, pp.2, 2013, https://doi.org/10.1007/s13277-013-1217-x
  3. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation vol.9, pp.None, 2014, https://doi.org/10.1186/s13014-014-0295-2
  4. Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel vol.46, pp.8, 2013, https://doi.org/10.1007/s11255-014-0664-7
  5. Inflammation‐based scores do not predict post‐transplant recurrence of hepatocellular carcinoma in patients within milan criteria vol.20, pp.11, 2013, https://doi.org/10.1002/lt.23969
  6. Meta-analysis of Associations between Interleukin-17 Gene Polymorphisms and Risk of Gastric Cancer vol.15, pp.20, 2013, https://doi.org/10.7314/apjcp.2014.15.20.8709
  7. Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score vol.41, pp.4, 2013, https://doi.org/10.5653/cerm.2014.41.4.151
  8. Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer vol.13, pp.None, 2013, https://doi.org/10.1186/s12957-015-0530-9
  9. Diurnal rhythms of serum and plasma cytokine profiles in healthy elderly individuals assessed using membrane based multiplexed immunoassay vol.13, pp.None, 2013, https://doi.org/10.1186/s12967-015-0477-1
  10. Neutrophil-lymphocyte Ratio Findings and Larynx Carcinoma: a Preliminary Study in Turkey vol.16, pp.1, 2013, https://doi.org/10.7314/apjcp.2015.16.1.351
  11. Effect of three common IL-17 single nucleotide polymorphisms on the risk of developing gastric cancer vol.9, pp.3, 2013, https://doi.org/10.3892/ol.2014.2827
  12. Preoperative neutrophil-to-lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancer vol.89, pp.2, 2013, https://doi.org/10.4174/astr.2015.89.2.81
  13. Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis vol.2016, pp.None, 2013, https://doi.org/10.1155/2016/7862469
  14. The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis vol.31, pp.2, 2013, https://doi.org/10.3904/kjim.2015.039
  15. Prognostic value of the neutrophil‐to‐lymphocyte ratio in patients with laryngeal squamous cell carcinoma vol.38, pp.suppl1, 2013, https://doi.org/10.1002/hed.24346
  16. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial vol.27, pp.4, 2013, https://doi.org/10.1093/annonc/mdw012
  17. Inflammation and chemerin in colorectal cancer vol.37, pp.5, 2013, https://doi.org/10.1007/s13277-015-4483-y
  18. The Preoperative Frailty Versus Inflammation-Based Prognostic Score: Which is Better as an Objective Predictor for Gastric Cancer Patients 80 Years and Older? vol.24, pp.3, 2013, https://doi.org/10.1245/s10434-016-5656-7
  19. Predictive Value of Preoperative Neutrophil Lymphocyte Ratio in Determining the Stage of Gastric Tumor vol.23, pp.None, 2013, https://doi.org/10.12659/msm.900681
  20. Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer vol.10, pp.None, 2013, https://doi.org/10.2147/ott.s138039
  21. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy vol.12, pp.3, 2013, https://doi.org/10.1371/journal.pone.0173955
  22. Prognostic Role of Neutrophil/Lymphocyte Ratio in Resected Gastric Cancer: A Systematic Review and Meta-analysis vol.73, pp.None, 2018, https://doi.org/10.6061/clinics/2018/e360
  23. Research Progress between Prognostic Nutrition Index and Prognosis of Gastrointestinal Cancer vol.7, pp.2, 2013, https://doi.org/10.12677/hjs.2018.72008
  24. The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies vol.13, pp.10, 2013, https://doi.org/10.1371/journal.pone.0202987
  25. Clinical Significance of Paraspinal Muscle Parameters as a prognostic factor for survival in Gastric Cancer Patients who underwent Curative Surgical Resection vol.11, pp.19, 2020, https://doi.org/10.7150/jca.46637
  26. Prognostic Value of Preoperative Prognostic Nutritional Index and Body Mass Index Combination in Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization vol.13, pp.None, 2013, https://doi.org/10.2147/cmar.s290983
  27. Prognostic value of the neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio and systemic immune‐inflammation index in patients with laryngeal squamous cell carci vol.46, pp.2, 2021, https://doi.org/10.1111/coa.13689
  28. Association between interleukin gene polymorphisms and susceptibility to gastric cancer in the Qinghai population vol.49, pp.5, 2021, https://doi.org/10.1177/03000605211004755